Back to Trades
RIEDEL NORBERT G
DirectorCIK 0001161662
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 7
- Buy transactions
- 0
- Sell transactions
- 1
- Companies
- 2
- Active
- 2025–2026
RIEDEL NORBERT G, Director, has filed 7 SEC reports (2025–2026), spread across 2 companies, totaling $2.8M in disclosed volume. Weighing $0 bought versus $655.7K sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
7 loaded
| Aug 7 | JAZZ Jazz Pharmaceuticals plc | RIEDEL NORBERT G | Director | Grant | $0 |
| Aug 4 | ETON Eton Pharmaceuticals, Inc. | RIEDEL NORBERT G | Director | Award | $0 |
| Apr 22 | ETON Eton Pharmaceuticals, Inc. | RIEDEL NORBERT G | Director | Exercise | $521.2K |
| Mar 2 | JAZZ Jazz Pharmaceuticals plc | RIEDEL NORBERT G | Director | Sell | $655.7K |
| Feb 5 | ETON Eton Pharmaceuticals, Inc. | RIEDEL NORBERT G | Director | Exercise | $265.2K |
| Jan 14 | ETON Eton Pharmaceuticals, Inc. | RIEDEL NORBERT G | Director | Award | $188.7K |
| Aug 11 | JAZZ Jazz Pharmaceuticals plc | RIEDEL NORBERT G | Director | Grant | $200.8K |
7 filings